• Around 14 million people were killed by Infectious diseases annually worldwide, i.e. 25% of the total death recorded.  Therefore, there is high prevalence rate of infectious diseases and increased demand for rapid diagnostic techniques due to slow turnaround time of current techniques.
• Infectious diseases point-of-care testing (POCT) market is set to rise from $696.1 million in 2015 to just over $1.17 billion by 2022 according to research and consulting firm GlobalData¹ 
• The rising demand for faster diagnosis and control of influenza due to the rapidly increasing prevalence of influenza.
• The global influenza diagnostics market is expected to reach USD 767.4 Million by 2021 from USD 508.0 Million in 2016² 

¹ https://health.economictimes.indiatimes.com/news/diagnostics/infectious-diseases- point-of-care-testing-market-will-rise-to-over-117-bn-by-2022-says-globaldata/53965042
² https://www.marketsandmarkets.com/PressReleases/influenza-diagnostic.asp

• Provide a wide range of the environmental characteristics as the sensing area contains spatially varying structures and a broader range of environmental properties can be sensed more effectively at specific structures.
• Low cost as the technology is based on image capturing by commercial image sensors, which can be faster and cheaper than then existing optical sensing system
• Increase of sensitivity by the specially designed image processing algorithms with unique and novel image recognition and machine learning based sensing method

• Medical devices products for:
  • Infectious diseases point-of-care testing 
  • influenza indicator

• US Provision Application No. 62/513,631